1.	Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma Phase: Phase III Type: Treatment Status: Completed Age: 18 to 90 Sponsor: Other Protocol IDs: FVF4290s, NCT00680225
2.	Phase I Pilot Study of In Situ Photoimmunotherapy Comprising Imiquimod and Infrared Laser Therapy With or Without Indocyanine Green in Patients With Stage III or IV Melanoma and Cutaneous Metastases. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 to 100 Sponsor: Other Protocol IDs: OU-12576, 12576, OU-ISPI, NCT00453050
3.	Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer Phase: Phase I Type: Diagnostic Status: Completed Age: Over 21 Sponsor: Other Protocol IDs: 2007P-000431, NCT00721370
4.	Fluorescent Dyes for Lymph Node Mapping Phase: Phase I Type: Diagnostic Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2009-0564, NCT01095913
5.	NIR-Guided Sentinel Lymph Node Mapping in Melanoma Phase: Phase I Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 10-039, NCT01121718
6.	Objective Flap Assessment During Reconstructive Surgery Phase: No phase specified Type: Diagnostic Status: Completed Age: Over 21 Sponsor: Other Protocol IDs: 2009P-000095/1; BIDMC, NCT00952107